AMAG Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
07 févr. 2019 07h00 HE
|
AMAG Pharmaceuticals, Inc.
Reaffirms 2019 Financial Guidance and Announces Consolidation of Women’s Health and Maternal Health Sales Forces Conference Call Scheduled for 8:00 a.m. ET Today WALTHAM, Mass., Feb. 07, 2019 ...
AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on Thursday, February 7, 2019 at 8:00 a.m. ET
30 janv. 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Jan. 30, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its fourth quarter and full year 2018 financial results will be released on Thursday,...
AMAG Pharmaceuticals Completes Acquisition of Perosphere Pharmaceuticals
17 janv. 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Jan. 17, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that it has completed the previously announced acquisition of Perosphere Pharmaceuticals...
AMAG Pharmaceuticals Appoints Christine Moulton Clemson, Ph.D., M.S.C.I. as Vice President of Medical Affairs
15 janv. 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Jan. 15, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Christine Moulton Clemson, Ph.D., M.S.C.I., as vice president, medical...
AMAG Pharmaceuticals Announces Preliminary 2018 Financial Results and Provides 2019 Financial Guidance
07 janv. 2019 07h00 HE
|
AMAG Pharmaceuticals, Inc.
Achieves 2018 revenue of between $471 million and $476 million, including approximately 28% growth in Feraheme® (ferumoxytol injection) sales Acquisition of two development-stage assets creates a...
AMAG Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference
19 déc. 2018 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Dec. 19, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, president and chief executive officer, will present at the...
AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals
13 déc. 2018 06h30 HE
|
AMAG Pharmaceuticals, Inc.
Next Generation Anticoagulant Reversal Agent, Ciraparantag, Will Add Innovative Clinical Stage Asset to AMAG’s Hematology Portfolio Conference call scheduled for 8:00 a.m. ET today WALTHAM, Mass.,...
Study of Feraheme demonstrates Improvements in Fatigue and Quality Of Life in Iron Deficiency Anemia Patients
03 déc. 2018 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that research supported by the Company, “Sustained Improvements in Fatigue and Quality of...
AMAG Pharmaceuticals Awards Four Grants to Further Research in Preterm Birth and Preeclampsia
29 nov. 2018 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- As part of the company’s annual grant program to support research to reduce preterm birth and preeclampsia and associated complications, AMAG...
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
06 nov. 2018 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate in the following investor conferences: Jefferies...